Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,242
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,844
Class I recallsReasonable probability of serious health consequences
24,383
Class II recallsTemporary or medically reversible health consequences
2,897
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,084 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,383
Class I9,844
Class III2,897
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,383
Class I9,844
Class III2,897
Not Yet Classified2

Showing 20,581–20,600 of 21,420 recalls

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Medroxyprogesterone 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Medroxyprogesterone 150 mg/ml,Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Latanoprost 0.025% eye drop, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Laser ophthalmic drops, 12 mL bottle, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Itraconazole 1% eye ointment, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Injection vehicle, 120 ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Hydroxyprogesterone 250 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

HCG 500 units/ml, 10 mL syringe, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

HCG 2000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

HCG 1000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Gentamicin buffered 36.4 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Estradiol Valerate 30 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Estradiol Valerate 20 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Estradiol Cypionate 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Diazepam 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Cyclosporine 2% ophthalmic, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Cyclosporine 1% ophthalmic drops, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Cataract drops, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Acetylcysteine 2 % Solution, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

FDA Recall TerminatedTerminated: February 22, 2017Historical recordClass II

Acetylcysteine 20 % solution, 100 ml bottle, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

by Clinical Specialties Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Published
July 10, 2013
Distribution
FL, GA and SC.

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.